Tissue culture, sequencing, and immunological reagents
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- CBER Acquisition Liaison cberacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring tissue culture, sequencing, and immunological reagents, including RNA sequencing supplies, human carriage kits, and tissue culture and immunoassay supplies as a new requirement. Solicitation release is estimated for January 1, 2027, with award anticipated by April 1, 2027.
The estimated award value ranges from $25,000 to $250,000. Inquiries should be directed to the FDA's acquisitions mailbox at cberacquisitions@fda.hhs.gov.
Forecast text
Tissue culture, sequencing, and immunological reagentsRNA SequencingSBA, OPAHuman carriage kitsTissue Culture and Immunoassay suppliesPriority 2, new requirement
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast